Clinical Trial: A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the Body in Healthy Adults.

U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07514156) titled 'A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the Body in Healthy Adults.' on July 03, 2025.

Brief Summary: The purpose of this study is to learn about the safety and tolerability of a study medicine called PF-07940369 when it is taken by mouth in different amounts and/or at multiples times a day by healthy adult participants. The study will also look at the pharmacokinetics of PF-07940369 (how the medicine is changed and eliminated from the body).

The study is seeking participants that are:

* male or female aged between 18 to 65 years

* have a body mass index (BMI) of 16...